Testing, Information Access Many question whether the initiative can adequately address issues of privacy and the need for education. The National Cancer Institute (NCI) is planning to launch a potentially controversial national information network in the fall. It will provide cancer genetic testing information to physicians and patients in an attempt to help them stay up-to-date, as well as access to the latest genetic testing protocols that NCI offers. IN FAVOR: OncorMed's Doug Dolginow b
Testing, Information Access
| Many question whether the initiative can adequately address issues of privacy and the need for education. |
 IN FAVOR: OncorMed's Doug Dolginow believes his firm will benefit from the network. |
The network is conceived as a "two-way street," says Barbara ...
A citizen science game explores how social choices and networks can influence how an illness moves through a population.
View this Issue
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
Learn how a next-generation platform accelerates biological research by enabling high-throughput, spatially resolved multiomics profiling.
In this webinar, Imogen Binnian will share how AI and gene synthesis technology can accelerate the discovery and validation of novel disease traits.
Real-time imaging enhances fluorescence activated cell sorting (FACS) to help scientists overcome the cost and burden of validation.
Industry-first smart HPLC system to provide authenticated user access verification on onboard touchscreen for superior security.
Setting new standards for intelligent mass detection, sensitivity, and sustainability.
Compact, Powerful, and now Mass Spec-Connected for Superior Analytical Performance
The Wellcome Sanger Institute, Helmholtz Munich, and Parse Biosciences have announced a landmark international collaboration to create a Cancer Plasticity Atlas.
